Skip to content
Posted on May 27, 2022 by: tove

宝尊电商2022Q1财报:增值性服务收入强劲增长 科技赋能助力品牌应对疫情冲击

Southeast Asia Chronicle

Latest News and Events

Posted on May 27, 2022 by: tove

宝尊电商2022Q1财报:增值性服务收入强劲增长 科技赋能助力品牌应对疫情冲击

  • Home
  • About Us
  • Contact Us
  • Term of Use
  • RSS

Tag: treatment

  • Home
  • treatment
Posted on March 25, 2022 by: tove

Angelalign Announces 2021 Annual Results

HONG KONG, Mar 25, 2022 – (ACN Newswire via SEAPRWire.com) – Angelalign Technology Inc. (“Angelalign” or “Company”; stock code 6699) was pleased to announce the …

Continue Reading
Posted on March 25, 2022 by: tove

Memiontec Secures its Largest Contract to date following Award of a New S$56.6 Million Contract by PUB

Singapore, Mar 25, 2022 – (ACN Newswire via SEAPRWire.com) – Memiontec Holdings Ltd. (“Memiontec” or the “Company”, and together with its subsidiaries, the “Group”), a …

Continue Reading
Posted on March 14, 2022 by: tove

IND Application for SinoMab’s First-in-Class Asthma Therapeutic Product SM17 Approved by FDA

HONG KONG, Mar 14, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock …

Continue Reading
Posted on February 17, 2022 by: tove

IND Application for SinoMab’s First-in-Class Asthma Therapeutic Product SM17 Accepted by FDA

HONG KONG, Feb 17, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock …

Continue Reading
Posted on January 3, 2022 by: gaia

China Everbright Water bags $67.6m wastewater treatment project in Shandong

Continue Reading
Posted on December 21, 2021 by: remi

Biogen Announces Reduced Price for Aduhelm to Improve Access For Patients With Early Alzheimer’s Disease In The United States

TOKYO, Dec 21, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that, effective January 1, 2022, Biogen will reduce the wholesale …

Continue Reading
Posted on December 20, 2021 by: remi

Eisai Enters into Commercialization and Distribution Agreement with Gilead for JAK Inhibitor Filgotinib in Asia

TOKYO, Dec 20, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. today announced it has entered into an agreement with Gilead Sciences, Inc. …

Continue Reading
Posted on December 2, 2021 by: tove

Gradiant Secures Five New DBOOM Projects in Indonesia and Vietnam, Appoints Managing Directors to Fuel Growth

Singapore, Dec 2, 2021 – (ACN Newswire via SEAPRWire.com) – Gradiant, a leading global cleantech water treatment solutions provider and projects developer, has announced the …

Continue Reading
Posted on November 11, 2021 by: remi

Eisai Presents Late-Breaker Updates on Lecanemab Clinical, Biomarker and Safety Data from Phase 2b Study Core and Open-Label Extension

TOKYO, Nov 11, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today results of new clinical, biomarker and safety …

Continue Reading
Posted on October 19, 2021 by: remi

Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment

TOKYO, Oct 19, 2021 – (JCN Newswire via SEAPRWire.com) – Aichi Cancer Center (1) and Fujitsu Limited today announced the development of an AI solution …

Continue Reading
Posted on September 28, 2021 by: remi

Eisai Initiates Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab (BAN2401) for Early Alzheimer’s Disease Under the Accelerated Approval Pathway

TOKYO, Sep 28, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. today announced that Eisai has initiated a rolling submission …

Continue Reading
Posted on September 16, 2021 by: ada

Gradiant Achieves Strong Growth Across Asia in Cleantech Water Treatment during the Pandemic

– Gradiant demonstrated strong growth during the prolonged COVID-19 pandemic– Gradiant won 26 new projects in 2021 YTD across the Asia Pacific region– Contract wins …

Continue Reading
Posted on September 6, 2021 by: tove

New treatment option for schizophrenia Reagila(R) listed on PBS

MELBOURNE, Sep 6, 2021 – (ACN Newswire via SEAPRWire.com) – A new treatment for schizophrenia in adults, Reagila(R) (cariprazine), was listed on the Pharmaceutical Benefits …

Continue Reading
Posted on July 30, 2021 by: remi

Eisai and Biogen Present Preliminary Assessment of the Clinical Effects of Lecanemab (BAN2401)

TOKYO, Jul 30, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. today announced results of a longitudinal preliminary assessment of …

Continue Reading
Posted on July 27, 2021 by: remi

Biogen and Eisai Announce ADUHELMTM (aducanumab-avwa) Data Presentations at Alzheimer’s Association International Conference 2021

TOKYO, Jul 27, 2021 – (JCN Newswire via SEAPRWire.com) – Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) today announced that Biogen, as part …

Continue Reading
Posted on June 9, 2021 by: tove

Central Global Bhd Signs MoU for JV to Build RM250M Kwasa Damansara Sewage Treatment Plant

KUALA LUMPUR, Jun 9, 2021 – (ACN Newswire via SEAPRWire.com) – Main Market-listed Central Global Berhad’s (“CGB) construction arm, Proventus Bina Sdn Bhd (“PBSB”), has …

Continue Reading
Posted on April 27, 2021 by: remi

MHIEC Supplies Incinerators for First Waste-to-Energy Plant in Xiaogan, Hubei Province, China

TOKYO, Apr 27, 2021 – (JCN Newswire via SEAPRWire.com) – Mitsubishi Heavy Industries Environmental & Chemical Engineering Co., Ltd. (MHIEC), a part of Mitsubishi Heavy …

Continue Reading
Posted on April 23, 2021 by: tove

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China – First Glucokinase Activator (GKA) Globally

SHANGHAI, CHINA, Apr 23, 2021 – (ACN Newswire via SEAPRWire.com) – Hua Medicine (the “Company”, Stock Code: 2552.HK), today announced that the New Drug Application …

Continue Reading
Posted on March 7, 2021 by: gaia

Insurance: Pay more if you see your own doctors

Unless you are prepared to pay more, the days of consulting private doctors who are not on your insurers’ panels for hospital treatment will soon …

Continue Reading
Posted on December 23, 2020 by: tove

Suntrap Life Technologies Discovers Natural anti-COVID-19 Compound

Guangzhou, China, Dec 23, 2020 – (ACN Newswire) – ‘LeSoleil’, a naturally active compound, was discovered as a therapeutic candidate for use against COVID-19. As …

Continue Reading

Latest News

  • 宝尊电商2022Q1财报:增值性服务收入强劲增长 科技赋能助力品牌应对疫情冲击 May 27, 2022
  • Jack Ma’s Ant ekes out profit rise as fintech overhaul advances May 27, 2022
  • EY evaluating strategic options to improve audit quality May 27, 2022
  • Evergrande to sell project in eastern China for $275 million May 27, 2022
  • Legend Capital’s Portfolio Company Feima Robotics Assists China’s 38th Antarctic Expedition with a Series of Civilian UAV Products May 27, 2022
  • PayPal begins cutting staff as its push to reduce costs ramps up May 27, 2022
  • Elon Musk sued by Twitter investors for ‘market manipulation’ during takeover bid May 27, 2022
  • NovationWire Press Release: Tailor Insight Reports on ‘Main Trends on Social Commerce 2022’ May 26, 2022
  • SEAPRWire与EQS集团达成媒体合作 May 26, 2022
  • Legend Capital’s Portfolio Company Feima Robotics Assists China’s 38rd Antarctic Expedition with a Series of Civilian UAV Products May 26, 2022
  • Samaiden Group Berhad’s 3Q Net Profit Gains 291% to RM4.19 Million May 26, 2022
  • Genetec Scales New Heights with Highest Annual Profit to Date May 26, 2022
  • SEAPRWire and EQS Group Enter into a Partnership in Media Cooperation May 26, 2022
  • Seng Fong Holdings Berhad Signs Underwriting Agreement with Hong Leong Investment Bank May 26, 2022
  • Showa Denko Announces Record Date for Extraordinary Shareholders’ Meeting May 26, 2022

Categories

  • ACN Newswire
  • Business
  • JCN Newswire
  • News
  • Top Story

Links

BBC News
Reuters
Bloomberg
Forbes
Newswire

Copyright © 2022 Southeast Asia Chronicle All Rights Reserved By Seachronicle.Com